Hookipa Pharma logo

Hookipa Pharma Share Price Today

(NASDAQ: HOOK)

Hookipa Pharma share price is $0.77 & ₹65.81 as on 18 Apr 2025, 2.30 'hrs' IST

$0.77

Market is closed - opens 7 PM, 21 Apr 2025

View live Hookipa Pharma share price in Dollar and Rupees. Guide to invest in Hookipa Pharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Hookipa Pharma, along with analyst recommendations, forecasts, and comprehensive financials.

Hookipa Pharma share price movements

  • Today's Low: $0.77
    Today's High: $0.81

    Day's Volatility :4.55%

  • 52 Weeks Low: $0.72
    52 Weeks High: $10.50

    52 Weeks Volatility :93.13%

Hookipa Pharma (HOOK) Returns

PeriodHookipa Pharma Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-62.09%
-2.8%
0.0%
6 Months
-80.62%
-11.0%
0.0%
1 Year
-89.45%
-1.9%
0.0%
3 Years
-95.37%
-1.5%
-12.9%

Hookipa Pharma (HOOK) Key Statistics

in dollars & INR

Previous Close
$0.7733
Open
$0.77
Today's High
$0.8067
Today's Low
$0.77
Market Capitalization
$9.3M
Today's Volume
$7.4K
52 Week High
$10.5
52 Week Low
$0.721
Revenue TTM
$43.9M
EBITDA
$-42.0M
Earnings Per Share (EPS)
$-3.47
Profit Margin
-98.99%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-61.68%

How to invest in Hookipa Pharma Stock (HOOK) from India?

It is very easy for Indian residents to invest directly in Hookipa Pharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Hookipa Pharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Hookipa Pharma or HOOK on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Hookipa Pharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Hookipa Pharma shares which would translate to 1.110 fractional shares of Hookipa Pharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Hookipa Pharma, in just a few clicks!

Returns in Hookipa Pharma (HOOK) for Indian investors in Rupees

The Hookipa Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Hookipa Pharma investment value today

Current value as on today

₹12,846

Returns

₹87,154

(-87.15%)

Returns from Hookipa Pharma Stock

₹89,495 (-89.5%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Hookipa Pharma (HOOK)

-9%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Hookipa Pharma Stock from India on INDmoney has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Hookipa Pharma

  • Baker Bros Advisors LP

    6.74%

  • Siren, L.L.C.

    4.70%

  • EcoR1 Capital, LLC

    3.22%

  • FMR Inc

    2.93%

  • Vanguard Group Inc

    1.77%

  • Redmile Group, LLC

    0.88%

Analyst Recommendation on Hookipa Pharma

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Hookipa Pharma(by analysts ranked 0 to 5 stars)

Analyst Forecast on Hookipa Pharma Stock (HOOK)

What analysts predicted

Upside of 484.42%

Target:

$4.50

Current:

$0.77

Insights on Hookipa Pharma Stock (Ticker Symbol: HOOK)

  • Price Movement

    In the last 1 month, HOOK stock has moved down by -36.6%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 4.70M → 1.35M (in $), with an average decrease of 71.2% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -13.84M → -24.95M (in $), with an average decrease of 80.3% per quarter
  • HOOK vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 165.6%
  • HOOK vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 124.2%
  • Price to Sales

    ForHOOK every $1 of sales, investors are willing to pay $0.2, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Hookipa Pharma Technicals Summary

Sell

Neutral

Buy

Hookipa Pharma is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Hookipa Pharma (HOOK) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Hookipa Pharma Inc. logo
-37.13%
-80.62%
-89.45%
-95.37%
-99.04%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Hookipa Pharma

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company's immuno-oncology pipeline includes HB-700, a novel next-generation multi-KRAS mutant-targeting investigational immunotherapy for the treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic cancers; Eseba-vec, an investigational immunotherapeutic agent in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers with enrollment completed in a Phase 1/2 clinical trial; and HB-300, which targets self-antigens for the treatment of prostate cancer. It is also developing HB-400 for the treatment of Hepatitis B that is in Phase I of clinical trial; and HB-500 for the treatment of Human Immunodeficiency Virus (HIV) that is in Phase I of clinical trial. The company has a collaboration and license agreement with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products for the treatment, cure, diagnosis, or prevention of the hepatitis B virus (HBV) and the HIV. HOOKIPA Pharma Inc. was incorporated in 2011 and is headquartered in New York, New York.
Organization
Hookipa Pharma
Employees
82
CEO
Dr. Malte Peters M.D.
Industry
Pharmaceuticals: Major

Management People of Hookipa Pharma

NameTitle
Dr. Malte Peters M.D.
CEO & Director
Ms. Mary Theresa Coelho M.B.A.
Executive VP, CFO, Compliance Officer & Director
Dr. Daniel D. Pinschewer M.D.
Co-Founder & Member of Scientific Advisory Board
Dr. Klaus Orlinger Ph.D.
Chief Scientific Officer
Dr. Mark Winderlich Ph.D.
Chief Research & Development Officer
Mr. Daniel Courtney
Corporate Secretary

Important FAQs about investing in HOOK Stock from India :

What is Hookipa Pharma share price today?

Hookipa Pharma share price today stands at $0.77, Open: $0.77 ; Previous Close: $0.77 ; High: $0.81 ; Low: $0.77 ; 52 Week High: $10.50 ; 52 Week Low: $0.72.

The stock opens at $0.77, after a previous close of $0.77. The stock reached a daily high of $0.81 and a low of $0.77, with a 52-week high of $10.50 and a 52-week low of $0.72.

Can Indians buy Hookipa Pharma shares?

Yes, Indians can invest in the Hookipa Pharma (HOOK) from India.

With INDmoney, you can buy Hookipa Pharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Hookipa Pharma at zero transaction cost.

How can I buy Hookipa Pharma shares from India?

It is very easy to buy Hookipa Pharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Hookipa Pharma (HOOK) be purchased?

Yes, you can buy fractional shares of Hookipa Pharma with INDmoney app.

What are the documents required to start investing in Hookipa Pharma stocks?

To start investing in Hookipa Pharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Hookipa Pharma Stock (HOOK)?

Today’s highest price of Hookipa Pharma (HOOK) is $0.81.

Today’s lowest price of Hookipa Pharma (HOOK) is $0.77.

What is today's market capitalisation of Hookipa Pharma?

Today's market capitalisation of Hookipa Pharma HOOK is 9.3M

What is the 52 Week High and Low Range of Hookipa Pharma Stock (HOOK)?

  • 52 Week High

    $10.50

  • 52 Week Low

    $0.72

What are the historical returns of Hookipa Pharma (HOOK)?

  • 1 Month Returns

    -37.13%

  • 3 Months Returns

    -80.62%

  • 1 Year Returns

    -89.45%

  • 5 Years Returns

    -99.04%

Who is the Chief Executive Officer (CEO) of Hookipa Pharma ?

Dr. Malte Peters M.D. is the current Chief Executive Officer (CEO) of Hookipa Pharma.